Antimicrobial use and bacterial resistance

Current Opinion in Microbiology

Volumn 3, Issue 5, 2000, Pages 496-501

  Monroe, Sara ^a   Polk, Ronald ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; COMPUTER ASSISTED DIAGNOSIS; DRUG COST; DRUG FORMULARY; MEDICAL EDUCATION; REVIEW; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS);

EID: 0033790692     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00129-6     Document Type: Review

References (52)

1. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)
2. Bacterial resistance in acne
3. Editorial response: Antibiotic armageddon
4. Antimicrobial management and cost containment
5. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
6. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcal infection
7. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients
8. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
9. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children?
10. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network
11. Development of resistance during antimicrobial therapy: A review of antibiotic classes and patient characteristics in 173 studies
12. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
13. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy
14. A review of the role of antibiotic policies in the control of antibiotic resistance
15. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: The AmpC enzymes
16. Antibiotic usage and methicillin-resistant Staphylococcus aureus: An analysis of causality
17. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control
18. Activites of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins
19. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
20. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia
21. Management of community-acquired pneumonia in the era of pneumococcal resistance
22. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
23. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
24. The epidemiology of intravenous vancomycin usage in a university hospital: A 10-year study
25. A cluster of vancomycin-resistant Enterococus faecium in an intensive care unit
26. Emergence of vancomycin-resistant enterococci in New York City
27. Recommendations for preventing the spread of vancomycin resistance
28. New intervention strategies for reducing antibiotic resistance
29. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci
30. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
31. Editorial response: Managing antibiotic use - Impact of infection control
32. Control of antimicrobial resistance in the health care system
33. Antibiotic use in humans and bacterial resistance
34. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
35. Antibiotic resistance - Squeezing the balloon?
36. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes
37. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci
38. Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
39. Antimicrobial control practices at 47 US hospitals: Are we doing enough?
40. Decreased antimicrobial resistance after changes in antibiotic use
41. Clinical and economic outcomes of a comprehensive antimicrobial management program
42. Programmatic role of the infectious disease physician in controlling antimicrobial costs in the hospital
43. Use of antimicrobial drugs before and after removal of a restriction policy
44. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program
45. A computer-assisted management program for antibiotics and other antiinfective agents
46. Antimicrobial cycling: Lessons learned from the aminoglycoside experience
47. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia
48. Strategies for study of the role of cycling on antimicrobial use and resistance
49. The microbial genetics of antibiotic cycling
50. Assessment of the relationship between antimicrobial usage and susceptibility: Differences between hospital and specific patient-care areas